Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1881-1890 of 2919 for cancer

Edit search filters
  1. A Study To Test Nivolumab With Usual Chemotherapy Treatment Or Usual Chemotherapy Treatment Alone To Treat Recurrent Or Metastatic Nasopharyngeal Cancer

    Jacksonville, FL, Rochester, MN

  2. Phase II Trial Of Irinotecan, Cetuximab, And Bevacizumab Compared With Irinotecan, Cetuximab, And Placebo In KRAS-Wildtype, Irinotecan-Refractory, Metastatic Colorectal Cancer

    Rochester, MN

  3. A Randomized, Double-blind, Phase 3 Efficacy Trial Of PROSTVAC-V/F +/- GM-CSF In Men With Asymptomatic Or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer

    Rochester, MN

  4. A Study To Evaluate Treating Post-Mastectomy Radiation Injury In Breast Cancer Patients With Adipose-Induced Regeneration Of Breast Skin (AIR Breast)

    Jacksonville, FL

  5. A Clinical Study Of MK-1084 With Targeted Therapy And Chemotherapy In People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Assessment Of The Efficacy And Safety Of Olaparib Monotherapy Versus Physicians Choice Chemotherapy In The Treatment Of Metastatic Breast Cancer Patients With Germline BRCA1/2 Mutations.

    Jacksonville, FL, Rochester, MN

  7. DAREON™-5: A Study To Test Whether Different Doses Of BI 764532 Help People With Small Cell Lung Cancer Or Other Neuroendocrine Cancers

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  8. Study Of Two Doses Of MK-3475 (Pembrolizumab) Versus Docetaxel In Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)

    Rochester, MN

  9. TAS-102 And Radiation Therapy In Treating Patients With Rectal Cancer That Is Locally Recurrent, Metastatic, Or Cannot Be Removed By Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Randomized Study Of Olaparib Or Placebo In Patients With Surgically Removed Pancreatic Cancer Who Have A BRCA1, BRCA2 Or PALB2 Mutation, The APOLLO Trial

    Rochester, MN

.

Mayo Clinic Footer